Bevacizumab (400mg)
Bryxta 400 mg Injection is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian cancer and cervical cancer.
1 Vial of 16 Ml
Zydus Cadila
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Bryxta 400 mg Injection is a anti-angiogenic medication. It works by blocking a protein called vascular endothelial growth factor (VEGF). This stops the formation of blood vessels that bring oxygen and nutrients to cancerous cells.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Bryxta 400 mg Injection may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Bryxta 400 mg Injection is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby.
Do not drive unless you are feeling well.
Sleepiness and fainting have been reported with Bryxta 400 mg Injection and this may impair your ability to drive.
Bryxta 400 mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Bryxta 400 mg Injection may not be needed in these patients. Please consult your doctor.
Bryxta 400 mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Bryxta 400 mg Injection may not be needed in these patients. Please consult your doctor.
